Earnings: PDL BioPharma, Vera Bradley, Colfax

  Positive Guidance

PDL BioPharma Guides Above Estimates
Wednesday, June 01, 2011  7:00:00 AM ET  
View:   Complete Article | Historical Guidance


PDL BioPharma Inc (PDLI) said it expects second quarter revenue of approximately $128.0 million. The current consensus estimate is revenue of $125.7 million for the quarter ending June 30, 2011.

  Inline Guidance

Vera Bradley Sees Second Quarter Above Estimates
Wednesday, June 01, 2011  4:01:09 PM ET  
View:   Complete Article | Historical Guidance


Vera Bradley, Inc. (VRA) said it expects second quarter earnings of $0.27 to $0.29 per share on revenue of $95.0 million to $98.0 million. The current consensus earnings estimate is $0.26 per share on revenue of $94.9 million for the quarter ending July 31, 2011. The company said it expects fiscal year earnings of $1.27 to $1.30 per share on revenue of $430.0 million to $435.0 million. The current consensus earnings estimate is $1.28 per share on revenue of $433.7 million for the year ending January 31, 2012.

Colfax Raises Guidance to be In-line with Estimates
Wednesday, June 01, 2011  6:05:00 AM ET  
View:   Complete Article | Historical Guidance


Colfax Corp (CFX) said it expects 2011 earnings of $1.12 to $1.22 per share. The company’s previous guidance was earnings of $1.00 to $1.10 per share and the current consensus earnings estimate is $1.19 per share for the year ending December 31, 2011.

Source: Earnings Whispers